Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-(2-((3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)methylamino)pyrimidin-5-yl)pyrrole-3-carboxamide
2. Ck-2127107
1. Ck-2127107
2. 1345410-31-2
3. Reldesemtiv [usan]
4. 4s0hbyw6qe
5. Reldesemtiv (usan)
6. 1-[2-({[trans-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methyl}amino)pyrimidin-5-yl]-1h-pyrrole-3- Carboxamide
7. 1-[2-[[3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methylamino]pyrimidin-5-yl]pyrrole-3-carboxamide
8. 1h-pyrrole-3-carboxamide, 1-(2-(((trans-3-fluoro-1-(3-fluoro-2-pyridinyl)cyclobutyl)methyl)amino)-5-pyrimidinyl)-
9. Unii-4s0hbyw6qe
10. Reldesemtiv [inn]
11. Schembl2566240
12. Chembl4297600
13. Schembl12288022
14. Schembl17584804
15. Gtpl11801
16. Ck-107
17. Db15256
18. Ck2127107
19. Hy-109121
20. Cs-0078343
21. J3.610.548h
22. D11363
23. 1-(2-(((trans-3-fluoro-1-(3-fluoro-2-pyridinyl)cyclobutyl)methyl)amino)-5-pyrimidinyl)- 1h-pyrrole-3-carboxamide
24. 1-(2-(((trans-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)methyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide
25. 1-[2-[[[3alpha-fluoro-1beta-(3-fluoro-2-pyridyl)cyclobutane-1-yl]methyl]amino]pyrimidine-5-yl]-1h-pyrrole-3-carboxamide
26. 1-[2-[[[trans-3-fluoro-1-(3-fluoro-2-pyridinyl)cyclobutyl]methyl]amino]-5-pyrimidinyl]-1h-pyrrole-3-carboxamide
| Molecular Weight | 384.4 g/mol |
|---|---|
| Molecular Formula | C19H18F2N6O |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | 384.15101554 g/mol |
| Monoisotopic Mass | 384.15101554 g/mol |
| Topological Polar Surface Area | 98.7 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 553 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of amyotrophic lateral sclerosis
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
70
PharmaCompass offers a list of Reldesemtiv API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Reldesemtiv manufacturer or Reldesemtiv supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Reldesemtiv manufacturer or Reldesemtiv supplier.
PharmaCompass also assists you with knowing the Reldesemtiv API Price utilized in the formulation of products. Reldesemtiv API Price is not always fixed or binding as the Reldesemtiv Price is obtained through a variety of data sources. The Reldesemtiv Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Reldesemtiv manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Reldesemtiv, including repackagers and relabelers. The FDA regulates Reldesemtiv manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Reldesemtiv API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Reldesemtiv supplier is an individual or a company that provides Reldesemtiv active pharmaceutical ingredient (API) or Reldesemtiv finished formulations upon request. The Reldesemtiv suppliers may include Reldesemtiv API manufacturers, exporters, distributors and traders.
Reldesemtiv Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Reldesemtiv GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Reldesemtiv GMP manufacturer or Reldesemtiv GMP API supplier for your needs.
A Reldesemtiv CoA (Certificate of Analysis) is a formal document that attests to Reldesemtiv's compliance with Reldesemtiv specifications and serves as a tool for batch-level quality control.
Reldesemtiv CoA mostly includes findings from lab analyses of a specific batch. For each Reldesemtiv CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Reldesemtiv may be tested according to a variety of international standards, such as European Pharmacopoeia (Reldesemtiv EP), Reldesemtiv JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Reldesemtiv USP).
